<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05610020</url>
  </required_header>
  <id_info>
    <org_study_id>FMASU M D 159/ 2021</org_study_id>
    <nct_id>NCT05610020</nct_id>
  </id_info>
  <brief_title>Heparin Binding Protein as a Prognostic Biomarker of Sepsis Severity</brief_title>
  <official_title>Heparin Binding Protein as a Reliable Prognostic Biomarker for Severity of Sepsis in the Intensive Care Unit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      the aim of the study is to correlate between the severity of sepsis and serum heparin binding&#xD;
      protein in the patients admitted to ICU with sepsis., and detect its value as a prognostic&#xD;
      biomarker in sepsis&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2021</start_date>
  <completion_date type="Actual">October 1, 2022</completion_date>
  <primary_completion_date type="Actual">August 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate the level of Heparin binding protein in relation to patient clinical improvement measured by SOFA Score</measure>
    <time_frame>72 hours after meeting sepsis ceriteria</time_frame>
    <description>Correlates the change of the level of Heparin binding protein in ng/ml to the clinical improvement of the patients which is measured by SOFA score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heparin binding protein and mortality</measure>
    <time_frame>28 days after meeting sepsis ceriteria</time_frame>
    <description>Correlates the change of the level of Heparin binding protein in ng/ml And how can it is used to predict mortality</description>
  </secondary_outcome>
  <enrollment type="Actual">55</enrollment>
  <condition>Sepsis</condition>
  <condition>HBP</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum blood sample&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        adult confirmed septic patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adult whose age between 20 to70 years old&#xD;
&#xD;
          -  patients suffered from sepsis or septic shock (under the third international consensus&#xD;
             definition of sepsis and septic shock)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any pregnancy female&#xD;
&#xD;
          -  Any patient who is Neutropenic secondary to malignancy&#xD;
&#xD;
          -  Patients who is taking immunosuppressive therapy&#xD;
&#xD;
          -  Patients who is suffering fromHematological malignancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Omar Hamdy</name>
      <address>
        <city>Minya</city>
        <zip>61511</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>October 20, 2022</study_first_submitted>
  <study_first_submitted_qc>November 5, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 8, 2022</study_first_posted>
  <last_update_submitted>November 5, 2022</last_update_submitted>
  <last_update_submitted_qc>November 5, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Omar Hamdy</investigator_full_name>
    <investigator_title>Specialist intensive care medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

